001     138081
005     20240826163725.0
024 7 _ |a 10.1186/s40478-015-0198-y
|2 doi
024 7 _ |a pmid:25853980
|2 pmid
024 7 _ |a pmc:PMC4369863
|2 pmc
024 7 _ |a altmetric:4029699
|2 altmetric
037 _ _ |a DZNE-2020-04403
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Ulusoy, Ayse
|0 P:(DE-2719)2772760
|b 0
|e First author
|u dzne
245 _ _ |a Neuron-to-neuron α-synuclein propagation in vivo is independent of neuronal injury.
260 _ _ |a London
|c 2015
|b Biomed Central
264 _ 1 |3 online
|2 Crossref
|b Springer Science and Business Media LLC
|c 2015-03-24
264 _ 1 |3 print
|2 Crossref
|b Springer Science and Business Media LLC
|c 2015-12-01
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1724674958_22476
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Interneuronal propagation of α-synuclein has been demonstrated in a variety of experimental models and may be involved in disease progression during the course of human synucleinopathies. The aim of this study was to assess the role that neuronal injury or, vice versa, cell integrity could have in facilitating interneuronal α-synuclein transfer and consequent protein spreading in an in vivo animal model.Viral vectors carrying the DNA for human α-synuclein were injected into the rat vagus nerve to trigger protein overexpression in the medulla oblongata and consequent spreading of human α-synuclein toward pons, midbrain and forebrain. Two vector preparations sharing the same viral construct were manufactured using identical procedures with the exception of methods for their purification. They were also injected at concentrations that induced comparable levels of α-synuclein transduction/overexpression in the medulla oblongata. α-Synuclein load was associated with damage (at 6 weeks post injection) and death (at 12 weeks) of medullary neurons after treatment with only one of the two vector preparations. Of note, neuronal injury and degeneration was accompanied by a substantial reduction of caudo-rostral propagation of human α-synuclein.Interneuronal α-synuclein transfer, which underlies protein spreading from the medulla oblongata to more rostral brain regions in this rat model, is not a mere consequence of passive release from damaged or dead neurons. Neuronal injury and degeneration did not exacerbate α-synuclein propagation. In fact, data suggest that cell-to-cell passage of α-synuclein may be particularly efficient between intact, relatively healthy neurons.
536 _ _ |a 342 - Disease Mechanisms and Model Systems (POF3-342)
|0 G:(DE-HGF)POF3-342
|c POF3-342
|f POF III
|x 0
536 _ _ |a 344 - Clinical and Health Care Research (POF3-344)
|0 G:(DE-HGF)POF3-344
|c POF3-344
|f POF III
|x 1
542 _ _ |i 2015-03-24
|2 Crossref
|u http://creativecommons.org/licenses/by/4.0
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 7 |a SNCA protein, human
|2 NLM Chemicals
650 _ 7 |a alpha-Synuclein
|2 NLM Chemicals
650 _ 2 |a Animals
|2 MeSH
650 _ 2 |a Brain: metabolism
|2 MeSH
650 _ 2 |a Disease Models, Animal
|2 MeSH
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Gene Transfer Techniques
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Medulla Oblongata: metabolism
|2 MeSH
650 _ 2 |a Nerve Degeneration: metabolism
|2 MeSH
650 _ 2 |a Nerve Degeneration: pathology
|2 MeSH
650 _ 2 |a Neural Pathways: metabolism
|2 MeSH
650 _ 2 |a Neural Pathways: pathology
|2 MeSH
650 _ 2 |a Neurons: metabolism
|2 MeSH
650 _ 2 |a Neurons: pathology
|2 MeSH
650 _ 2 |a Parkinson Disease: metabolism
|2 MeSH
650 _ 2 |a Rats
|2 MeSH
650 _ 2 |a Rats, Sprague-Dawley
|2 MeSH
650 _ 2 |a alpha-Synuclein: metabolism
|2 MeSH
700 1 _ |a Musgrove, Ruth E
|0 P:(DE-2719)2810507
|b 1
|u dzne
700 1 _ |a Rusconi, Raffaella
|0 P:(DE-2719)2810495
|b 2
|u dzne
700 1 _ |a Klinkenberg, Michael
|0 P:(DE-2719)2810845
|b 3
|u dzne
700 1 _ |a Helwig, Michael
|0 P:(DE-2719)2810665
|b 4
|u dzne
700 1 _ |a Schneider, Anja
|0 P:(DE-2719)2812035
|b 5
|u dzne
700 1 _ |a Di Monte, Donato A
|0 P:(DE-2719)2481741
|b 6
|e Last author
|u dzne
773 1 8 |a 10.1186/s40478-015-0198-y
|b : Springer Science and Business Media LLC, 2015-03-24
|n 1
|p 13
|3 journal-article
|2 Crossref
|t Acta Neuropathologica Communications
|v 3
|y 2015
|x 2051-5960
773 _ _ |a 10.1186/s40478-015-0198-y
|g Vol. 3, no. 1, p. 13
|0 PERI:(DE-600)2715589-4
|n 1
|q 3:1<13
|p 13
|t Acta Neuropathologica Communications
|v 3
|y 2015
|x 2051-5960
856 7 _ |2 Pubmed Central
|u http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4369863
856 4 _ |u https://pub.dzne.de/record/138081/files/DZNE-2020-04403.pdf
|y OpenAccess
856 4 _ |u https://pub.dzne.de/record/138081/files/DZNE-2020-04403.pdf?subformat=pdfa
|x pdfa
|y OpenAccess
909 C O |o oai:pub.dzne.de:138081
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 0
|6 P:(DE-2719)2772760
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 1
|6 P:(DE-2719)2810507
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 2
|6 P:(DE-2719)2810495
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 3
|6 P:(DE-2719)2810845
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 4
|6 P:(DE-2719)2810665
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 5
|6 P:(DE-2719)2812035
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 6
|6 P:(DE-2719)2481741
913 1 _ |a DE-HGF
|b Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-342
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Disease Mechanisms and Model Systems
|x 0
913 1 _ |a DE-HGF
|b Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-344
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 1
914 1 _ |y 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a Creative Commons Attribution CC BY (No Version)
|0 LIC:(DE-HGF)CCBYNV
|2 V:(DE-HGF)
|b DOAJ
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b ACTA NEUROPATHOL COM : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b ACTA NEUROPATHOL COM : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
920 1 _ |0 I:(DE-2719)1013008
|k AG Di Monte
|l Neurodegeneration and Neuroprotection in Parkinson´s Disease
|x 0
920 1 _ |0 I:(DE-2719)1440011
|k AG Schneider Göttingen
|l Translational Dementia Research Göttingen
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1013008
980 _ _ |a I:(DE-2719)1440011
980 _ _ |a UNRESTRICTED
980 1 _ |a FullTexts
999 C 5 |9 -- missing cx lookup --
|a 10.1016/S0197-4580(02)00065-9
|2 Crossref
|o 10.1016/S0197-4580(02)00065-9
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s00702-002-0808-2
|2 Crossref
|o 10.1007/s00702-002-0808-2
999 C 5 |9 -- missing cx lookup --
|a 10.1073/pnas.0903691106
|2 Crossref
|o 10.1073/pnas.0903691106
999 C 5 |9 -- missing cx lookup --
|a 10.1172/JCI43366
|2 Crossref
|o 10.1172/JCI43366
999 C 5 |9 -- missing cx lookup --
|a 10.1084/jem.20112457
|2 Crossref
|o 10.1084/jem.20112457
999 C 5 |9 -- missing cx lookup --
|a 10.1002/ana.23747
|2 Crossref
|o 10.1002/ana.23747
999 C 5 |9 -- missing cx lookup --
|a 10.1093/brain/awt037
|2 Crossref
|o 10.1093/brain/awt037
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s00401-013-1160-3
|2 Crossref
|o 10.1007/s00401-013-1160-3
999 C 5 |9 -- missing cx lookup --
|a 10.1002/ana.24066
|2 Crossref
|o 10.1002/ana.24066
999 C 5 |9 -- missing cx lookup --
|a 10.1523/JNEUROSCI.2102-14.2014
|2 Crossref
|o 10.1523/JNEUROSCI.2102-14.2014
999 C 5 |9 -- missing cx lookup --
|a 10.1126/science.1227157
|2 Crossref
|o 10.1126/science.1227157
999 C 5 |9 -- missing cx lookup --
|a 10.1002/emmm.201302475
|2 Crossref
|o 10.1002/emmm.201302475
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.neuron.2011.08.033
|2 Crossref
|o 10.1016/j.neuron.2011.08.033
999 C 5 |9 -- missing cx lookup --
|a 10.1186/1750-1326-7-42
|2 Crossref
|o 10.1186/1750-1326-7-42
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s00441-012-1428-2
|2 Crossref
|o 10.1007/s00441-012-1428-2
999 C 5 |9 -- missing cx lookup --
|a 10.1038/ncomms5755
|2 Crossref
|o 10.1038/ncomms5755
999 C 5 |9 -- missing cx lookup --
|a 10.1089/10430349950016942
|2 Crossref
|o 10.1089/10430349950016942
999 C 5 |9 -- missing cx lookup --
|a 10.1016/S0166-2236(98)01362-9
|2 Crossref
|o 10.1016/S0166-2236(98)01362-9
999 C 5 |9 -- missing cx lookup --
|a 10.1111/j.1365-2818.1987.tb02837.x
|2 Crossref
|o 10.1111/j.1365-2818.1987.tb02837.x
999 C 5 |9 -- missing cx lookup --
|a 10.1111/j.1699-0463.1988.tb00954.x
|2 Crossref
|o 10.1111/j.1699-0463.1988.tb00954.x
999 C 5 |9 -- missing cx lookup --
|a 10.1038/nmeth.2019
|2 Crossref
|o 10.1038/nmeth.2019
999 C 5 |y 2009
|2 Crossref
|t The rat brain in stereotaxic coordinates
|o G Paxinos The rat brain in stereotaxic coordinates 2009
999 C 5 |9 -- missing cx lookup --
|a 10.1046/j.1365-2818.2002.01006.x
|2 Crossref
|o 10.1046/j.1365-2818.2002.01006.x
999 C 5 |9 -- missing cx lookup --
|a 10.1046/j.1365-2818.1999.00457.x
|2 Crossref
|o 10.1046/j.1365-2818.1999.00457.x
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s00401-012-0964-x
|2 Crossref
|o 10.1007/s00401-012-0964-x
999 C 5 |9 -- missing cx lookup --
|a 10.1038/8470
|2 Crossref
|o 10.1038/8470
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.expneurol.2007.09.011
|2 Crossref
|o 10.1016/j.expneurol.2007.09.011
999 C 5 |9 -- missing cx lookup --
|a 10.1089/hum.2010.055
|2 Crossref
|o 10.1089/hum.2010.055
999 C 5 |9 -- missing cx lookup --
|a 10.1002/cne.902110304
|2 Crossref
|o 10.1002/cne.902110304
999 C 5 |9 -- missing cx lookup --
|a 10.1523/JNEUROSCI.02-10-01424.1982
|2 Crossref
|o 10.1523/JNEUROSCI.02-10-01424.1982
999 C 5 |9 -- missing cx lookup --
|a 10.1016/0165-1838(84)90008-0
|2 Crossref
|o 10.1016/0165-1838(84)90008-0
999 C 5 |9 -- missing cx lookup --
|a 10.1002/cne.902240102
|2 Crossref
|o 10.1002/cne.902240102
999 C 5 |9 -- missing cx lookup --
|a 10.1016/0361-9230(85)90091-7
|2 Crossref
|o 10.1016/0361-9230(85)90091-7
999 C 5 |9 -- missing cx lookup --
|a 10.1016/0306-4522(91)90163-I
|2 Crossref
|o 10.1016/0306-4522(91)90163-I
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.ymthe.2005.11.007
|2 Crossref
|o 10.1016/j.ymthe.2005.11.007
999 C 5 |y 1986
|2 Crossref
|o A Albanese 1986
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.nbd.2011.12.013
|2 Crossref
|o 10.1016/j.nbd.2011.12.013
999 C 5 |9 -- missing cx lookup --
|a 10.1093/brain/aws133
|2 Crossref
|o 10.1093/brain/aws133
999 C 5 |9 -- missing cx lookup --
|a 10.1074/jbc.M113.451815
|2 Crossref
|o 10.1074/jbc.M113.451815
999 C 5 |9 -- missing cx lookup --
|a 10.1038/nm.3457
|2 Crossref
|o 10.1038/nm.3457


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21